Acurx Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACXP and other ETFs, options, and stocks.

About ACXP

Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme. 

CEO
David P. Luci
CEODavid P. Luci
Employees
4
Employees4
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2017
Founded2017
Employees
4
Employees4

ACXP Key Statistics

Market cap
7.16M
Market cap7.16M
Price-Earnings ratio
-0.47
Price-Earnings ratio-0.47
Dividend yield
Dividend yield
Average volume
229.93K
Average volume229.93K
High today
$0.33
High today$0.33
Low today
$0.3044
Low today$0.3044
Open price
$0.33
Open price$0.33
Volume
375.48K
Volume375.48K
52 Week high
$3.33
52 Week high$3.33
52 Week low
$0.30
52 Week low$0.30

People also own

Based on the portfolios of people who own ACXP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.